银发经济或成下一个风口(共8份)
银发经济或成下一个风口
-
艾媒咨询|2021年中国夜间用药年度观察报告
本报告涉及的案例/品牌/企业:美团买药,叮当快药
在众多社会服务中,夜间用药成为人们最关注的夜间社会服务之一,近年来,各地相关行政管理机构也陆续出台相关扶持政策,鼓励商家上线夜间送药平台、发展24小时药店,提供夜间送药服务,推动解决“夜间买药难”问题。近日,iiMedia Research(艾媒咨询)最新发布《2021年中国夜间用药年度观察报告》,基于2021年初至2021年末的监测数据,对中国夜间用药市场持续追踪。报告显示,年初有61.2%的用户夜间生病选择忍,而年底这一数字降至52.1%,据推算年末夜间用药受益群体新增约4000万人。报告指出,日渐成熟的中国外卖送药平台,成为解决夜间用药的重要参与者。通过一年的发展,在美团买药“小黄灯”计划等24小时药店惠民工程的推动下,线上24小时药店数量增加、夜间买药配送速度更快、服务保障更加成熟,用户知晓度有了较大提升,夜间买药难的问题得到有效缓解。
Among many social services,night medication has become one of the night social services that people pay most attention to. In recent years,relevant administrative agencies around the country have also successively issued relevant support policies to encourage businesses to launch night medication delivery platforms,develop 24-hour pharmacies,provide night medication delivery services, and promote the solution of the problem of "difficulty in buying drugs at night". Recently, iiMedia Research released the annual observation report on nighttime medication in China in 2021,which continuously tracks China's nighttime medication market based on the monitoring data from the beginning of 2021 to the end of 2021. The report shows that at the beginning of the year, 61.2% of users chose to tolerate illness at night,while at the end of the year,the figure fell to 52.1%. It is estimated that about 40 million people will benefit from night medication at the end of the year.The report points out that the increasingly mature Chinese takeout delivery platform has become an important participant in solving the problem of night medication. Through one year's development,driven by the 24-hour pharmacy benefit project such as the "small yellow light" plan of meituan drug purchase, the number of online 24-hour pharmacies has increased,the speed of drug purchase and distribution at night is faster,the service guarantee is more mature,the user awareness has been greatly improved,and the problem of difficult drug purchase at night has been effectively alleviated. -
艾媒报告 |2019中国消费者线上快递寄件专题研究报告
本报告研究涉及企业/品牌/案例:菜鸟裹裹,京东快递,顺丰速运,支付宝,淘宝,中国邮政,微信
在快递业基础设施和服务水平持续改善的推动下,中国寄件市场规模不断扩大,2019年第一季度快递订单规模达121.5亿件,同比增长了22.5%。同时,为解决寄件行业中的诸多痛点,快递行业通过数字化转型,积极开展线上寄件业务。线上寄件市场呈爆发式增长,其用户规模也在不断扩大,预计在2019年将突破1.6亿人。iiMedia Research(艾媒咨询)数据显示,54.1%的受访网民认为线上寄件为他们节省了超过10分钟,同时, 61.7%的受访网民认为通过线上寄件的形式节省了超10%的费用。通过线上寄件平台体验测评和对比,结果显示,菜鸟裹裹综合体验领先各平台,成高性价比快递业务首选。线上寄件通过标准化的服务,不仅为消费者带来了更高性价比、效率和服务体验的寄件业务,同时推动快递行业服务价值体系的进一步完善。
Driven by the improvement of express infrastructure and service level, the scale of the delivery market has enlarged continually. The amount of express orders in the first quarter of 2019 was 12.15 billion, increased by 22.5% from the same period of last year. Meanwhile, to solve the existing problems of the delivery industry, the express industry starts to focus on the online express delivery business. The scale of the online delivery market has increased dramatically and it is estimated that the user scale will exceed 160 million in 2019. As the data of iiMedia Research showed, 54.1% of the interviewed users believed that the online delivery service helps them save more than 10 minutes, and 61.7 % interviewed users considered that the service helps them save more than 10% of the costs. According to the comparison of different online delivery platforms, Cainiao Post becomes the first choice of cost-effective express business. With the standardized service, online delivery business not only brings the higher cost performance, more effective and better experience service to the customers but also motivates the improvement of the whole industry value. -
艾媒咨询|2021年夜间用药行业研究报告
本报告研究涉及企业/品牌/案例:美团,京东到家,饿了么
国内人口基数增长以及人们对于健康管理意识的增强,使得夜间用药市场的需求度也保持在较高的水平。iiMedia Research(艾媒咨询)数据显示,约89.9%受访者表示近一年有过夜间生病或者家人朋友需要用药的经历,并且,群众对夜间用药种类的需求丰富,并且在夜间各个时段的急性疾病需求都普遍较高。为此,04年起政府已经倡导24小时药店以满足用户需求。但是研究发现,“晚上买药难”是夜间生病人士普遍提及的关键词,即时配送平台兴起或成解决夜间用药新机遇。
The growth of the domestic population base and the increase of people's awareness of health management have kept the demand for night medication in the market at a relatively high level. According to data from iiMedia Research, about 89.9% of the interviewees said that they have had the experience of getting sick at night or needing medication at night in the past year. Moreover, the masses have a rich demand for medication at night, and acute illnesses at various times during the night. Disease needs are generally high. For this reason, since 2004, the government has advocated 24-hour pharmacies to meet user needs. However, the study found that "difficult to buy medicine at night" is a key word commonly mentioned by people who are sick at night. The rise of instant delivery platforms may be a new opportunity to solve night medicine. -
艾媒咨询|2021全球与中国医药电商市场与发展趋势研究报告
本报告研究涉及企业/品牌/案例:阿里健康,美团,京东健康,叮当快药,1药网,Walgreens,百度健康,药材买卖网,中药材天地网,找药网,九州通,药易购,珍诚医药在线,CVS
在政策利好、互联网技术等多重因素推动下,中国医药电商行业规模持续快速发展,2020年中国医药电商市场交易规模达到1956亿元。当前,中药电商商业模式主要为B2B、B2C、O2O与DTP四种类型,其中,2020年,医药电商B2C模式占比近6%,市场规模为116亿元;医药电商B2C模式占比近84%,市场规模为1640亿元,成为当前的主流。此外,近几年兴起的O2O模式,主要通过“引流-转化-消费-反馈”等实现盈利,而DTP药房模式下,患者在医院开取处方后,药房根据处方以患者或家属指定的时间和地点送药上门,被称为高值新特药直送平台。
Driven by favorable policies, Internet technology and other factors, the scale of China's pharmaceutical e-commerce industry continues to develop rapidly, with the transaction scale of China's pharmaceutical e-commerce market reaching 1956 billion yuan in 2020. At present, the business models of traditional Chinese medicine e-commerce are mainly B2B, B2C, o2o and DTP. In 2020, the B2C model of pharmaceutical e-commerce accounts for nearly 6% and the market scale is 11.6 billion yuan; the B2C model of pharmaceutical e-commerce accounts for nearly 84% and the market scale is 164 billion yuan, which has become the current mainstream. In addition, the o2o mode, which has sprung up in recent years, mainly achieves profits through "drainage transformation consumption feedback". In the DTP pharmacy mode, after patients get prescriptions in the hospital, the pharmacy delivers drugs to the door at the time and place designated by the patients or their families according to the prescriptions, which is known as the high value new special drugs direct delivery platform. -
艾媒报告|2020年中国后疫时代医疗防护行业及细分领域分析报告
本报告研究涉及企业/品牌/案例:欣龙控股,振德医疗,奥美医疗,尚荣医疗,际华集团,蓝帆医疗,兵装集团;其他提及企业/品牌:金三发科技,中国石油,赢合科技,鑫台铭,斯凯瑞,CM朝美,华东医药,爱马斯,海王星辰,北京同仁堂,拼多多,天猫,京东,上海通用五菱,比亚迪,龙头股份,华纺股份,水星家纺,红豆股份
2020年4月3日,全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020年中国后疫时代医疗防护行业及细分领域分析报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据,对2020年中国医疗防护行业及其细分领域的口罩、防护服、手套、护目镜等进行分析。此外,报告探讨产业上下游的运营模式,结合对欣龙控股、振德医疗、奥美医疗、尚荣医疗、际华集团、蓝帆医疗和兵装集团等典型企业的案例分析,对钢铁行业总体运行情况进行分析,并结合新冠疫情对2020-2021年中国医疗防护产业发展进行趋势预判。相较于发达国家,中国的医疗防护行业起步晚,防护水平低,由于医疗防护用品属于低值耗材,所以国内市场的品牌化理念也不强。但是,随着近些年中国经济的发展,国内的医疗防护市场逐渐升温,新老企业都有了品牌意识。在未来的发展道路上,品牌化和专业化将成为国内医疗防护用品生产企业的核心竞争力。
The outbreak of new crown pneumonia has raised awareness of personal protection, and the market potential for medical protective supplies is huge, and China's demand for medical protective equipment such as masks and gloves is expected to grow rapidly. In addition, the global outbreak of the new crown has also become a great opportunity for the export of China's medical protection products. As the first region to erupt in the outbreak, China has the first advantage of medical protective supplies, and the production capacity of medical protective supplies can be exported overseas. -
艾媒研报 |丽人丽妆:化妆品电商蓬勃发展,线上代运营进入量质转化阶段
本报告研究涉及企业/品牌/案例:丽人丽妆、卡尼尔、小护士、希思黎、奥伦纳素、雪花秀、兰芝、施华蔻、相宜本草、兰芝、雪花秀、雅漾、芙丽芳丝、巴黎欧莱雅、雪肌精、Crescent Lily、上海丽仁、Milestone、Asia-Pacific、阿里巴巴、Crescent Group、麦顿投资、汉理资本、唯品会、聚美优品、欧莱雅集团、爱茉莉太平洋贸易有限公司、汉高集团、佳丽宝化妆品(中国)有限公司、上药康德乐(上海)医药有限公司、上海相宜云商电子商务有限公司、杭州悠可、网创科技、宝尊电商、若羽臣
随着社会、经济、文化的快速变迁,中国居民的价值观和消费习惯逐渐发生变化,人们对形象的要求和认知逐步提高。化妆品不再是年轻女性的专属,越来越多的男性开始注重自身形象管理,他们对化妆品的关注程度不断上升,年轻男性尤为活跃,消费潜力十足。在消费人群不断拓展、消费能力逐渐提升、以及销售渠道多元化等多重因素作用下,中国化妆品行业景气度持续上涨,化妆品市场规模稳步扩张。2018年,中国限额以上企业化妆品销售额达到2619.0亿元,同比增长4.2%,化妆品消费额占社会消费品零售总额的比例上升至1.6%。丽人丽妆是较早成立的阿里系化妆品电商零售服务商,受益于阿里系电商平台的流量红利,发展较为快速。但随着传统电商平台用户数量趋于饱和以及新兴电商平台的分流作用,线上获客成本不断攀升,公司的运营成本压力骤增。此外,电商环境以及消费者偏好的变化也影响着化妆品品牌的销售渠道策略,在面对这些不确定性因素时,公司目前单一运营渠道的隐患也逐渐暴露,增长趋缓。
With the rapid changes of society, economy and culture, the values and consumption habits of Chinese residents have gradually changed, and people's image requirements and perceptions have gradually improved. Cosmetics are no longer exclusive to young women. More and more men begin to pay attention to their image management. They pay more attention to cosmetics. Young men are especially active and have full consumption potential. With the continuous expansion of the consumer population, the gradual improvement of consumption capacity and the diversification of sales channels, the prosperity of China's cosmetics industry continues to rise, and the scale of the cosmetics market has steadily expanded. In 2018, the cosmetics sales of Enterprises above the quota reached 261.9 billion yuan, an increase of 4.2% over the same period last year, and the proportion of cosmetics consumption in the total retail sales of consumer goods rose to 1.6%. Lily&Beauty is an early established Ali cosmetics e-commerce retail service provider, benefiting from the flow dividend of Ali e-commerce platform, which develops rapidly. However, as the number of users of traditional e-commerce platforms tends to be saturated and the diversion role of emerging e-commerce platforms, the cost of online customer acquisition keeps rising, and the pressure of operating costs of the company increases sharply. In addition, changes in e-commerce environment and consumer preferences also affect the marketing channel strategy of cosmetics brands. In the face of these uncertainties, the company's current single channel of operation has gradually exposed the hidden dangers, slowing down the growth. -
艾媒报告 |2019全球与中国医药电商市场与发展趋势研究报告
本报告研究涉及企业/品牌/案例:天猫医馆,七乐康,京卫大药房,阿里健康大药房,京东大药房,健客, 1药网,360好药,八百方,818医药网,CVS,Walgreens ,RiteAid ,开心人网上药店,药房网,药材买卖网,珍材网,中药材天地网,商康网,科欣医药,医药在线,我的医药网,药品交易网,药品终端网,药师帮,海王晨星,快方送药,药给力,搜药送,药急送,U医U药,叮当送药,健客网上药店,康爱多掌上药店,问药,好药师,111集团,中宏保险,医联,腾讯,仁和药业,浙江扁鹊,漱玉平民,华人健康,一树药业,德生堂
2019中国医药电商主要形成了B2C、B2B、O2O三种模式,B2C模式体量稳定在6%左右,规模呈增长趋势,预计2019年的市场交易额将达到554.6亿元;B2B模式下,西药类产品的需求比例较高,达87.1%,中药材、传统药品和第三方交易等都形成了专属B2B平台;而近几年兴起的O2O模式,主要通过“引流-转化-消费-反馈”等实现盈利,但区域覆盖度和消费者的信任度需要提高。iiMedia Research(艾媒咨询)大数据监测显示,目前1药网、健客网上药店、康爱多掌上药店的的综合实力排行较强。
2019 China's pharmaceutical e-commerce mainly formed three modes of B2C, B2B and O2O. The volume of B2C model is stable at around 6%, and the scale is increasing. It is expected that the market transaction volume in 2019 will reach 55.46 billion yuan; in B2B mode, western medicine The demand ratio of products is relatively high, reaching 87.1%. Chinese herbal medicines, traditional medicines and third-party transactions have formed a proprietary B2B platform. In recent years, the O2O model has emerged mainly through “drainage-conversion-consumption-feedback”. Achieve profitability, but regional coverage and consumer trust need to be improved. iiMedia Research (Ai Media Consulting) big data monitoring shows that the current comprehensive strength of 1 drug network, Jianke online pharmacy, Kang Aiduo pharmacy is strong.
- 1
- 2
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告